Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Research To Practice | Oncology Videos · Jun 9, 2026 · 58m

Featuring perspectives from Dr Christine L Hann and Dr Jacob Sands, including the following topics:

Introduction: Biopharmacology of Small Cell Lung Cancer — "Wildfire sparked in dry grass" (0:00)

Limited-Stage Disease (9:22)

Extensive-Stage Disease (16:23)

Paraneoplastic Syndromes — Lambert-Eaton Myasthenic Syndrome (23:54)

Bispecific T-Cell Engagers — Tarlatamab (30:00)

Antibody-Drug Conjugates — Ifinatamab Deruxtecan (39:19)

Other Novel Agents — Alisertib, Chimeric Antigen Receptor T-Cell Therapy (52:54)

CME information and select publications